PAVmed PAVM Cash Flow Statement (2015-2026)

NASDAQ PAVM
$1.65 +0.10 (+6.45%)
At close: Nov 6, 2026 · 4:00 PM EST
Reported Financials

PAVmed Quarterly Cash Flow Statement

Periods 46 quarters
Latest Jun 2026

PAVmed reported cash from operations of -$2.68M and free cash flow of -$2.69M for the quarter ended Jun 2026, down 131.2% year over year. This cash flow statement covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-13.67M-19.68M-19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M60.71M66.58M18.62M-12.32M-6.01M-2.76M-6.60M
Depreciation and DepletionDep. & Depletion
0.09M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
0.12M
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.03M0.17M0.22M0.82M0.70M0.73M0.73M0.75M0.73M0.73M0.59M0.31M0.24M0.07M0.04M0.02M0.02M0.02M0.02M0.02M
Share-based CompensationStock Comp.
3.99M4.38M4.81M5.01M4.76M4.95M4.42M2.51M2.25M1.97M1.88M1.90M1.93M0.73M0.93M0.16M0.38M0.23M0.92M
Gains from Sales and DivestituresGains Divest
1.00M
Gains from Investment SecuritiesGains Investment
-0.26M-0.03M0.41M0.13M21.00M-10.64M-4.38M2.50M-2.50M
Other non-cash itemsOther Non-Cash
-3.72M0.03M2.00M9.99M-5.26M2.76M1.08M6.16M1.01M2.53M1.33M1.16M1.53M0.05M0.10M-0.24M1.59M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.11M-0.09M0.03M-0.01M0.01M0.01M-0.01M0.03M0.01M0.15M-0.20M0.00M-0.01M-0.01M0.01M0.01M-0.01M
Change in Account PayablesChange Payables
2.26M-2.74M3.92M-2.87M-2.04M0.24M-1.44M-0.10M1.00M-0.38M-0.30M-0.25M0.30M0.19M-0.29M0.02M-0.05M0.34M0.30M0.08M
Change in Accrued ExpensesChange Accrued Exp.
0.04M2.63M-1.59M0.26M0.00M0.78M0.02M1.22M0.54M1.02M0.15M0.13M-1.23M0.63M-0.24M0.49M-0.12M-0.18M-0.39M0.37M
Change in Other Operating AssetsOther Assets Change
0.48M1.54M0.13M1.53M-1.10M-0.96M0.33M1.27M0.17M-1.51M-0.53M0.15M-0.20M-0.25M-0.19M0.45M-0.35M-0.02M-0.07M0.49M
Other Working Capital ChangesOther WC Changes
-0.48M-1.54M-0.13M-1.53M1.10M0.96M-0.33M-1.27M-0.17M1.51M0.53M-0.15M0.20M0.25M0.19M-0.45M0.35M0.02M0.07M-0.49M
Cash from OperationsCash from Ops.
-8.02M-16.78M-12.26M-22.56M-19.34M-16.82M-16.36M-12.71M-11.09M-11.87M-13.11M-11.66M-8.88M0.09M-1.60M-1.16M-0.94M-1.51M-2.62M-2.68M
Investing Activities
Capital ExpendituresCapex
0.04M1.28M0.57M0.35M0.32M0.30M0.03M0.02M0.02M0.18M0.04M0.00M0.01M0.00M0.01M0.01M0.00M0.01M0.02M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
1.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.04M-1.28M-0.57M-0.35M-0.32M-0.30M0.97M-0.02M-0.02M-0.18M-0.04M0.00M-0.01M0.00M-0.01M-0.01M0.00M-0.01M-0.02M-0.01M
Acquisitions
0.10M2.10M1.00M
Net of Acquisitions & DivestmentsNet Acquisitions
-0.10M-2.10M-1.00M
Cash from Investing ActivitiesCash from Investing
-0.14M-3.38M-0.57M-2.55M-1.32M-0.30M0.97M-0.02M-0.02M-0.18M-0.04M0.00M-16.14M0.00M-0.01M-0.01M0.00M-0.01M-0.02M-0.01M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
10.23M10.00M15.00M
Long-Term Debt RepaymentsLT Debt Repayment
0.32M0.21M11.15M
Net Long-Term Debt Issued (Repaid)Net LT Debt
10.23M10.00M-0.32M-0.21M3.85M
Net Debt Issuances and RepaymentsNet Debt Issuance
10.23M10.00M-0.32M-0.21M3.85M
Change in Capital Stock
Common Stock IssuedStock Issued
2.28M65.28M0.24M0.06M0.36M0.08M0.74M0.61M0.08M0.37M0.85M0.20M0.28M-1.27M0.84M4.02M-4.02M-0.84M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
2.28M65.28M0.24M0.06M0.36M0.08M0.74M0.61M0.08M0.37M0.85M0.20M0.28M-1.27M0.84M4.02M-4.02M-0.84M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
13.63M5.00M18.17M11.63M3.71M
Net Equity Issued and RepurchasedNet Equity Issued
2.28M65.28M0.24M0.06M0.36M0.08M14.36M0.61M0.08M5.37M19.02M11.83M0.28M-1.27M0.84M4.02M-4.02M-0.84M3.71M
Other financing activities (as filed)
-0.11M
Cash from Financing ActivitiesCash from Financing
2.28M60.07M0.32M25.53M12.29M0.08M24.92M0.61M0.35M5.29M19.05M11.62M0.28M0.33M3.10M2.49M0.00M7.56M
Additional items
Change in Cash
-5.87M39.92M-12.52M0.42M-8.37M-17.04M9.54M-12.12M-10.76M-6.77M5.90M-0.04M-24.73M0.42M1.52M1.30M-0.90M-1.57M4.92M-2.68M
Ending Cash Balance
37.34M77.26M64.74M65.15M56.79M39.74M49.28M37.16M26.41M19.64M25.54M25.50M0.77M1.19M2.70M4.00M3.10M1.54M3.78M
Free Cash FlowFCF
-8.05M-18.05M-12.84M-22.91M-19.66M-17.12M-16.39M-12.73M-11.11M-12.06M-13.15M-11.66M-8.89M0.09M-1.61M-1.17M-0.94M-1.52M-2.64M-2.69M
Net Cash FlowNCF
-5.87M39.92M-12.52M0.42M-8.37M-17.04M9.54M-12.12M-10.76M-6.77M5.90M-0.04M-24.73M0.42M1.50M1.32M-0.95M-1.52M4.92M-2.69M

PAVmed Cash Flow Statement API

Pull PAVmed's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PAVM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY